Type 5 Phosphodiesterase Inhibitors: Curing Erectile Dysfunction
- 30 June 2006
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 49 (6) , 942-945
- https://doi.org/10.1016/j.eururo.2006.02.063
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?European Urology, 2006
- Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitorsWorld Journal of Urology, 2005
- Resumption of Spontaneous Erections in Selected Patients Affected by Erectile Dysfunction and Various Degrees of Carotid Wall Alteration: Role of TadalafilEuropean Urology, 2005
- Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular RiskEuropean Urology, 2005
- Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and DiseaseJournal of Andrology, 2003
- Acute and Prolonged Effects of Sildenafil on Brachial Artery Flow-Mediated Dilatation in Type 2 DiabetesDiabetes Care, 2002
- Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled studyUrology, 2000
- Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonismInternational Journal Of Impotence Research, 2000
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- ImpotenceJAMA, 1993